Showing results (1511-1520 of 1,634) with videos related to

Sort By:
Pageof 164
American Heart Journal|February 12, 2026
Design and rationale of A Multicenter Paramedic randomized trial of noradrenaline versus adrenaline in the initial management of patients with cardiogenic shock - The PANDA trialJason E Bloom, Jocasta Ball, Daniel Okyere, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 27, 2024
Long-Term Follow-Up of Anti-Infliximab Antibodies in Patients With Radiographic Axial Spondyloarthritis: A Marker of Drug Survival and TaperingClarissa Q Pimentel, Ana Cristina Medeiros-Ribeiro, Andrea Y Shimabuco, et al.
Leukemia|July 13, 2026
Randomized phase 2 trial of CPX-351 vs. CLAG-M (cladribine, cytarabine, G-CSF, and mitoxantrone) for medically unfit adults with acute myeloid leukemia or other high-grade myeloid neoplasmsAnna B Halpern, Megan Othus, Mary-Elizabeth M Percival, et al.
Leukemia|May 4, 2018
Phase 1/2 trial of GCLAM with dose-escalated mitoxantrone for newly diagnosed AML or other high-grade myeloid neoplasmsAnna B Halpern, Megan Othus, Emily M Huebner, et al.
Blood Advances|February 20, 2020
Outpatient intensive induction chemotherapy for acute myeloid leukemia and high-risk myelodysplastic syndromeFrances Linzee Mabrey, Kelda M Gardner, Kathleen Shannon Dorcy, et al.
Mabs|January 5, 2021
Activity of murine surrogate antibodies for durvalumab and tremelimumab lacking effector function and the ability to deplete regulatory T cells in mouse models of cancerDarren J Schofield, Jennifer Percival-Alwyn, Mateusz Rytelewski, et al.
European Journal of Haematology|September 6, 2023
Hyper-CVAD versus dose-adjusted EPOCH as initial treatment for adults with acute lymphoblastic leukemiaLucas C Zarling, Philip A Stevenson, Lorinda A Soma, et al.
Journal of Autoimmunity|March 29, 2011
Therapeutic dosing of an orally active, selective cathepsin S inhibitor suppresses disease in models of autoimmunityMark Baugh, Darcey Black, Paul Westwood, et al.
Human Molecular Genetics|October 11, 2019
ADAMTS9 and ADAMTS20 are differentially affected by loss of B3GLCT in mouse model of Peters plus syndromeBernadette C Holdener, Christopher J Percival, Richard C Grady, et al.
Nature Communications|October 21, 2018
The reaction of hydroxyl and methylperoxy radicals is not a major source of atmospheric methanolRebecca L Caravan, M Anwar H Khan, Judit Zádor, et al.
Pageof 164